HIV Treatment Strategies

The Latest

This Week in HIV Research: I Screen, You Screen, We All Screen for HPV-Related Cancers

May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.

By Barbara Jungwirth and Myles Helfand

Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital

When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.

By Sony Salzman

This Week in HIV Research: Unexpected Outcomes

May 2, 2019: patient-centered care model improves viral suppression; subpar immune responses when baseline CD4 tops 500; when CD4 plummets despite viral suppression; vaccination, immunoglobulin, and hepatitis A exposure.

By Barbara Jungwirth and Myles Helfand

Why Do Study Participants Misreport Their HIV Status?

A new study demonstrates the phenomenon, but experts say more research needs to determine why it occurs -- and what researchers can do differently to reduce it.

By Barbara Jungwirth

Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.

By Kenyon Farrow

Depression Linked to Cognitive Dysfunction in HIV-Positive Women

More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.

By Martha Kempner

Researchers Crave More Data on HIV Care Continuum Programs for Recently Incarcerated People

Sixteen years after the success of Project START for HIV risk reduction, we still don't know what works best for helping people with HIV stay in care after prison.

By Sony Salzman

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

By Barbara Jungwirth and Myles Helfand

CDC: Most HIV Transmissions Are From People Who Are Not in Care

More than 80 percent of U.S. HIV transmissions in 2016 were from people who were unaware of their status or had been diagnosed but lost to follow-up.

By Stephen Hicks

This Week in HIV Research: Exorcizing Our PrEP Demons

Experts push for normalization of PrEP; U.S. HIV transmission rates across the care continuum; sociodemographic disadvantage and HIV drug resistance; real-world success of integrase inhibitors for treatment-experienced people.

By Myles Helfand